Michael is an experienced digital marketer, with extensive social media, organizational, financial, product lifecycle and business development expertise. He has led cross-disciplined teams in a wide variety of online/offline, media and communications projects, and is dedicated to disseminating the transformative science of stem & cell therapeutics through digital advocacy.

Online Marketing | Project Management | Digital Media | Communications | Advertising | Content Development | Scientific Analysis & Outreach/Engagement Programs

In 2008 Michael chose to investigate the emerging field of medical innovation. This decision was driven by family & issues relating to health. By applying his analytical skills he became familiar with the technologies & players involved. After years of fundamental research Michael established “@msemporda,” the dog, as a social media vehicle to focus on communicating analysis & developments in the RegenMed & Cell Therapy field. By way of independent community engagement he has built a diverse following. From his origins as an online voice supporting the sector’s investor community, to his expanding presence in social media & engagement projects with the scientific community, he has now established himself as a noted SciComm Analyst & Sector Advocate.

"Advocacy for Cures"​ through Social Media Outreach/Engagement & On-Site at Industry Conferences & Events. 


 youtube  scoop.it  twitter  google+  linkedin



@msemporda - Stem Cell Sector Analyst / SciComms - 2008 - Present
Santa Barbara area, California, US

Independent biotech product marketing advocate and consultant in the regenerative medicine technology sector: digital media platform communications; stakeholder community building; social media outreach; industry engagement; product analysis reporting; business development; patient advocacy and investor support.

Active on various public & community platforms & via dedicated scientific forums, including as a contributor to CCRM's SignalsPaul Knoepfler's BlogStem Cell Assays by Alexey Bersenev.